Necrotizing Fasiitis

Embed Size (px)

Citation preview

  • 8/17/2019 Necrotizing Fasiitis

    1/30

      N  E  C

      R  O   T  I  Z

      I  N  G

       F  A  S

      I  I   T  I  S

  • 8/17/2019 Necrotizing Fasiitis

    2/30

  • 8/17/2019 Necrotizing Fasiitis

    3/30

    OUTLINE

    Defnition

    Risk actors

    Classifcation

    Pathophysiology

    Symptoms

    Investigations

    Treatment

  • 8/17/2019 Necrotizing Fasiitis

    4/30

    WHAT IS NECROTIZING FASCIITIS?

    It is a progressive, rapidly spreading, inammatoryinection located in the deep ascia with secondarynecrosis o the s!ctaneos tisse""

    inection rapidly destroy the skin and sot tisse

    !eneath it#lso known as$ “esh%eating” !acteria"

    &ther names$ '%hemolytic streptococcal gangrene,(eleney lcer, acte dermal gangrene, hospitalgangrene, and necroti)ing celllitis"

    * types o +"Type I : a polymicrobial fora.

    Type II Grop A !"S#r$p#ococc% bac#$ria &mo%# commo'ca%$(

    Type III : mari'$ )ibrio *ram"'$*a#i)$ ro+%.

  • 8/17/2019 Necrotizing Fasiitis

    5/30

     T,-E I NECROTIZING FASCIITIS

    (i-ed aero!ic and anaero!ic inection

    .acteria almost always isolated

    S" ares, Streptococci, /nterococci, /"coli, Peptostreptococcs spp,Prevotella, Porphyromonas, ." ragilis,and Clostridim spp"

    (ore common in dia!etics, post op pt,and pt with peripheral vasclar disease"

  • 8/17/2019 Necrotizing Fasiitis

    6/30

    • C$r)ical '$cro#ii'* /a%cii#i%

    L+0i*1% a'*i'a &L+0i*2% a'*i'a i% a' i'/$c#io' o/ #3$foor o/ #3$ mo#3 '+$r #3$ #o'*$. I# i% +$ #o

    bac#$ria(• For'i$r1% *a'*r$'$

    Ca%$+ by p$'$#ra#io' o/ #3$ GI or r$#3ral mco%a by$'#$ric or*a'i%m%

    /or'i$r2% *a'*r$'$: A 3orr$'+o% i'/$c#io' o/ #3$ *$'i#alia

    #3a# ca%$% %$)$r$ pai' i' #3$ *$'i#al ar$a &i' #3$ p$'i%a'+ %cro#m or p$ri'$m( a'+ pro*r$%%$% /rom $ry#3$ma&r$+'$%%( #o '$cro%i% &+$a#3( o/ #i%%$.Ga'*r$'$ ca' occr0i#3i' 3or%. T3$ mor#ali#y &+$a#3( ra#$% ar$ p #o 567

  • 8/17/2019 Necrotizing Fasiitis

    7/30

     T,-E II NECROTIZING FASCIITIS

    (onomicro!ial

    Grop A S#r$p 8RSA & m$#3icilli' r$%i%#a'# %#ap3ylococc% ar$% (

    Can occr in any age grop and in healthy patients

    Risk actors H9o bl'# #rama or lac$ra#io' aric$lla I';$c#io' +r* %$ -o%# op -o%# par#m

  • 8/17/2019 Necrotizing Fasiitis

    8/30

  • 8/17/2019 Necrotizing Fasiitis

    9/30

     T,-E III

    Type * % 0ram%negative monomicro!ial inection$

    This incldes marine organisms sch as 1i!riospp" and #eromonas hydrophila, which canoccr ollowing seawater contamination owonds, in2ries involving fsh fns or stings,and raw seaood consmption % particlarly in

    patients with chronic liver disease"

    These marine inections are particlarly virlentand can !e atal within 34 hors"

  • 8/17/2019 Necrotizing Fasiitis

    10/30

  • 8/17/2019 Necrotizing Fasiitis

    11/30

    RIS> FACTOR

    Immnocompression illnesses

    e"g"$ D(, Cancer, alcoholism, vasclarins5ciency, organ transplant, 6I1 ornetropenia"

     Trama or oreign !odies in srgical wond"

    Idiopathic as scrotal or penile necroti)ingasciitis"

  • 8/17/2019 Necrotizing Fasiitis

    12/30

    -ATHO-H,SIOLOG,

    .acteria eat away at tisse !etween skin andmscle

    Increase in sensitivity or anaesthetic eel to theskin itsel 

    Inammatory response !y immne system

    .acterial to-ins released e-oto-in #Cytokines impede nction o phagocytic cells A'a$rob$% #3ri)$ %p$$+i'* p '$cro#ic proc$%%

    /ndothelial cells !ecome damaged7 I'cr$a%$+ p$rm$abili#y o/ #3$ li'i'* o/ )$%%$l% i' #3$

    bo+yPoor !lood spply inhi!it$ I'famma#ory r$%po'%$ proc$%% Abili#y /or #3$ imm'$ %y%#$m #o prop$rly 0or Abili#y #o #ra'%/$r a'#ibio#ic% #o #3$ a@$c#$+ /a%cial lay$r

    1asoconstriction and throm!osis  edema  h o-ia necrosis o the ascia skin sot

  • 8/17/2019 Necrotizing Fasiitis

    13/30

    S8(PT&(S

    Compari'* #3$ 'i'/$c#$+ %i' #o #3$ $arly a'+ a+)a'c$+/orm% o/ #3$ +i%$a%$:

    Normal %i' Early %#a*$ A+)a'c$+ %#a*$ 

  • 8/17/2019 Necrotizing Fasiitis

    14/30

  • 8/17/2019 Necrotizing Fasiitis

    15/30

  • 8/17/2019 Necrotizing Fasiitis

    16/30

    CRITICAL S,8-TO8SThe critical symptoms orm in the

    last stages o +"*:< o patient=s develop

    hemorrhagic !llae which maycase them to !ecome anemic"

    1asclatre o the skin !ecomesinamed and throm!osed"Reslting in necrotic eschars

    that look like deep thermal!rns"

    >ithot treatment, secondaryinvolvement o deeper msclelayers may occr"

    Patients may !ecome nm!

    !ecase o nerve damage andprogressing gangrene in theinected area"

    ?nconsciosness will occr as the!ody !ecomes too weak tofght o@ the inection alongwith a severe decrease in thepatient=s !lood pressre"

    #s to-ins are !eing released, the=

  • 8/17/2019 Necrotizing Fasiitis

    17/30

    EBA8S AN= LA

  • 8/17/2019 Necrotizing Fasiitis

    18/30

    INESTIGATIONS

    Imaging Stdies$

     %ray

     gas in the s!ctaneosascia planes"

      D"D" o s!ctaneos gas in a

    radiograph"

    C"T"  demonstrating necrosis with

    asymmetric ascial thickening  E gas in the tisses"

    (RI scans may help to show the e-tent o tisse involvement!t may not !e accrate and shold not delay srgery"

    ?ltrasond has also !een sed to show s!ctaneos gas" F93G

    http://patient.info/doctor/necrotising-fasciitis-pro#ref-14http://patient.info/doctor/necrotising-fasciitis-pro#ref-14

  • 8/17/2019 Necrotizing Fasiitis

    19/30

  • 8/17/2019 Necrotizing Fasiitis

    20/30

    INESTIGATION

    Comptedtomography

    demonstratessot tisse gascollection rom aninvasive 0rop #

    Streptococci.acteria"

    Gas

    vesicles

    Gas

    vesicles

     

  • 8/17/2019 Necrotizing Fasiitis

    21/30

  • 8/17/2019 Necrotizing Fasiitis

    22/30

     TREAT8ENT

    /arly and aggressive srgical e-ploration andde!ridement

    R$$plora#io' %3ol+ b$ p$r/orm$+ 09i' D 3r%

    #nti!iotic therapy

     Typ$ I: ampicilli' or 'a%y' 0i#3 cli'+amyci' or fa*yl I/ r$c$'# 3o%pi#alia#io' %$ o%y' or #im$'#i' i'%#$a+ o/ 'a%y'.

     Typ$ II: -CN G a'+ cli'+amyci' )a'comyci'

    6emodynamic spport

    Intravenos immnoglo!lin Hcrrently nder

    investigation, !t not recommended6yper!aric o-ygen therapy

  • 8/17/2019 Necrotizing Fasiitis

    23/30

  • 8/17/2019 Necrotizing Fasiitis

    24/30

    Cetria-one HRocephin

    Cetria-one is the drg o choice in initial treatment" It is athird%generation cephalosporin with !road%spectrm, gram%negative activity" It has lower e5cacy against gram%positive

    organisms and higher e5cacy against resistant organisms" Itarrests !acterial growth !y !inding to one or more penicillin%!inding proteins"

    0entamicin

    0entamicin is an aminoglycoside anti!iotic or gram%negativecoverage" It is sed in com!ination with !oth an agent againstgram%positive organisms and one that covers anaero!es" It isnot the drg o choice, !t shold !e considered i penicillinsor other less to-ic drgs are contraindicated, when clinicallyindicated, and in mi-ed inections cased !y sscepti!lestaphylococci and gram%negative organisms"

    #d2st the dose !ased on creatinine clearance HCrCl andchanges in volme o distri!tion" ollow each regimen !y atleast a trogh level drawn on the third or orth dose H:" h!eore dosing" Peak level may !e drawn :" h ater a *:%mininsion

  • 8/17/2019 Necrotizing Fasiitis

    25/30

    Chloramphenicol

    Chloramphenicol !inds to : S !acterial%ri!osomals!nits and inhi!its !acterial growth !y inhi!iting

    protein synthesis" It is e@ective against gram%negativeand gram%positive !acteria"

    #mpicillin

    #mpicillin has !actericidal activity against sscepti!leorganisms" It is an alternative to amo-icillin when the

    patient is na!le to take medication orally" It may !eadded to the initial regimen i the 0ram stain sggeststhat enterococci are present"

    Imipenem and cilastatin HPrima-in

    This com!ination is sed or treatment o inectionsde to mltiple organisms in which other agents donot have wide%spectrm coverage or arecontraindicated !ecase o potential or to-icity"

  • 8/17/2019 Necrotizing Fasiitis

    26/30

    #mpicillin and sl!actam H?nasyn

    This com!ination o ampicillin and a !eta%

    lactamase inhi!itor covers skin, enteric ora,and anaero!es" It is not ideal or treatment onosocomial pathogens"

    1ancomycin H1ancocin

    1ancomycin is an anti!iotic directed againstgram%positive organisms and active against/nterococcs species" It is sel in thetreatment o septicemia and skin%strctreinections" 1ancomycin is indicated or

    patients who cannot take or whose conditionsail to respond to penicillins andcephalosporins or those with inections withresistant staphylococci"

    To prevent to-icity, the crrent

  • 8/17/2019 Necrotizing Fasiitis

    27/30

    H,-ER

  • 8/17/2019 Necrotizing Fasiitis

    28/30

    -REENTION

    (ost people are in goodhealth !eore they !ecomeinected"

    Degrees to lessen yorchances

    ba%ic 3y*i$'ic prac#ic$% &0a%3i'*3a'+%(

    $$p all 0o'+% cl$a'

    0a#c3 /or %i*'% o/ i'/$c#io' &i'cr$a%$pai' %0$lli'* p% 3$a# or /$)$r(

    %$$ imm$+ia#$ m$+ical a##$'#io' i/3a)$ %ymp#om% o/ f$%3"$a#i'*

    +i%$a%$ a'+

    3a)$ pr$ca#io' i/ i' clo%$ co'#ac#

    0i#3 %om$o'$ 0i#3 #3$ bac#$ria. 

  • 8/17/2019 Necrotizing Fasiitis

    29/30

    -ICTURES

  • 8/17/2019 Necrotizing Fasiitis

    30/30